127 related articles for article (PubMed ID: 227758)
21. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
22. [Urinary gonadotropin fragment measurement in the monitoring of trophoblastic disease].
Fu CY; Cole LA; Kardana A
Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):475-7, 510-1. PubMed ID: 7835119
[TBL] [Abstract][Full Text] [Related]
23. Affinity to lectin, biological and immunological characteristics of human chorionic gonadotropins from pregnant women and trophoblastic tumour patients.
Koyama K; Toda K; Kuriyama D; Isojima S
Acta Endocrinol (Copenh); 1986 Aug; 112(4):579-85. PubMed ID: 3019056
[TBL] [Abstract][Full Text] [Related]
24. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
[TBL] [Abstract][Full Text] [Related]
25. [Gonadotropin of chorioepithelioma -- its heterogeneity -- (author's transl)].
Mizusawa T
Nihon Naibunpi Gakkai Zasshi; 1975 Dec; 51(12):997-1014. PubMed ID: 823055
[TBL] [Abstract][Full Text] [Related]
26. Assessment of rapid radioimmunoassay for urinary beta-human chorionic gonadotropin (beta hCG-RIA) in early pregnancy.
Xu RQ; Li YY; Zhou SZ; Fei RT; Liu YH
Acta Acad Med Wuhan; 1984; 4(2):105-8. PubMed ID: 6204259
[TBL] [Abstract][Full Text] [Related]
27. [Development of two assay systems of desialylated hCG specific for O-serine or N-asparagine linked carbohydrate chain and their clinical application].
Imamura S
Nihon Naibunpi Gakkai Zasshi; 1985 Jul; 61(7):753-64. PubMed ID: 3934006
[TBL] [Abstract][Full Text] [Related]
28. Thyrotropic activity of basic isoelectric forms of human chorionic gonadotropin extracted from hydatidiform mole tissues.
Yoshimura M; Pekary AE; Pang XP; Berg L; Goodwin TM; Hershman JM
J Clin Endocrinol Metab; 1994 Apr; 78(4):862-6. PubMed ID: 8157712
[TBL] [Abstract][Full Text] [Related]
29. [The course of hydatidiform moles, followed by the radio-immunological estimation of choriogonadotrophin (author's transl)].
Roger M; Gauthier J; Feinstein-Soldat MC; Tardy J; Scholler R
Nouv Presse Med; 1977 Oct; 6(33):2967-71. PubMed ID: 593833
[TBL] [Abstract][Full Text] [Related]
30. Human chorionic gonadotropin alpha-subunit in pregnancy.
Benveniste R; Scommegha A
Am J Obstet Gynecol; 1981 Dec; 141(8):952-61. PubMed ID: 6172038
[TBL] [Abstract][Full Text] [Related]
31. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG.
Cole LA; Kardana A; Andrade-Gordon P; Gawinowicz MA; Morris JC; Bergert ER; O'Connor J; Birken S
Endocrinology; 1991 Sep; 129(3):1559-67. PubMed ID: 1714836
[TBL] [Abstract][Full Text] [Related]
32. Improved monitoring of gestational trophoblastic neoplasia using a highly sensitive assay for urinary human chorionic gonadotropin.
Wehmann RE; Ayala AR; Birken S; Canfield RE; Nisula BC
Am J Obstet Gynecol; 1981 Aug; 140(7):753-7. PubMed ID: 6266253
[TBL] [Abstract][Full Text] [Related]
33. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
[TBL] [Abstract][Full Text] [Related]
34. Molecular heterogeneity of hCGbeta--related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-32. PubMed ID: 9833612
[TBL] [Abstract][Full Text] [Related]
35. Semiquantitative use of Biocept-G radioreceptorassay.
Hussa RO; Mattingly RF
Obstet Gynecol; 1979 Aug; 54(2):199-204. PubMed ID: 460754
[TBL] [Abstract][Full Text] [Related]
36. Molecular heterogeneity of human chorionic gonadotropin in serum and urine from patients with trophoblastic tumors.
Hoermann R; Spoettl G; Grossmann M; Saller B; Mann K
Clin Investig; 1993 Nov; 71(11):953-60. PubMed ID: 8312691
[TBL] [Abstract][Full Text] [Related]
37. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
Norman RJ; Buck RH; Joubert SM
S Afr Med J; 1989 Apr; 75(7):318-9. PubMed ID: 2538933
[TBL] [Abstract][Full Text] [Related]
38. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
Kitajima T; Mochizuki M; Nishimura R
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
[TBL] [Abstract][Full Text] [Related]
39. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
